Shezad Malik MD JD

Invokana Feet and Toes Amputation Lawsuit

Invokana Feet and Toes Amputation Lawsuit. Johnson & Johnson the world’s largest pharmaceutical and medical device maker and it’s Janssen subsidiary are under fire over serious allegations that the companies failed to warn about severe side effects from its blockbuster […]

James Humann

MDL Court Denies Cook Medical’s Motion for Summary Judgment as to the Defective Design of its IVC Filter and Finds that Defendants Argued the Wrong Law 

With less than two weeks before the start of the first bellwether trial in the Cook Medical IVC multidistrict litigation, on October 10, 2017, the Court issued an Order denying Defendant Cook’s Motion for Summary Judgment as to negligence and strict liability design defect claims. The denial was at least partially due to the Defendant’s arguing the wrong legal standard under Florida law.

Kenneth Brennan

US Supreme Court Refuses to Restrict Personal Jurisdiction in Landmark Paxil Case

The U.S. Supreme Court allowed to stand an appellate court decision stating that a product manufacturer is subject to personal jurisdiction for product-related claims in a state where development or testing occurred, dealing a huge blow to the well-funded big pharma legal teams who may well now find themselves defending their drugs and medical devices in all fifty states.

Derek T. Braslow

Risperdal Trials Set for Next Month as Number of New Cases Continues to Grow

Mass tort cases continue to pile up for Johnson & Johnson (J&J) and their subsidiaries.  So is the case with Risperdal, a treatment for bipolar disorder and schizophrenia that was first approved by the Food and Drug Administration (FDA) in […]

John W. Fraser

Understanding Michigan’s Medical Marijuana Laws: Section 4 Immunity under the MMMA

This post is the second in a series of posts designed toward providing some basic background information about the legal status of marijuana under Michigan law. Our first post covered some general background of 2008’s Michigan Medical Marihuana Act (commonly […]

Matthew Sill

Fulmer Sill Helps Communities Harmed by Opioid Epidemic

For years now, local and tribal governments across the United States have been financially burdened by an epidemic of opioid abuse, addiction, and overdoses that has plagued their communities. The economic cost the opioid epidemic places on communities today is […]

M. Brandon Smith

FDA Seeks to Prevent Pharmaceutical Companies from Abusing ‘Orphan Drug’ Law

Recently, I discussed a couple of reports that have come to light, potentially exposing the shortcomings of an FDA policy on “fast tracking” the approval of certain new drugs. Now, the FDA is in the middle of a large operation […]

Thomas Greer

Is It Enough? Tennessee Task Force Makes Opioid Crisis Recommendations

After months of investigation and deliberation, the Tennessee task force on opioid abuse released their recommendations earlier this month. Created by Tennessee House Speaker Beth Harwell (R-Nashville), the goal was to not only work on new legislation, but also to determine […]

Roopal Luhana

Drug Meant to Compete with Actemra Unlikely to Gain FDA Approval

On August 2, 2017, Janssen Biotech, Inc., a subsidiary of Johnson & Johnson (J&J), announced that the Arthritis Advisory Committee of the U.S. FDA did not recommend approval for the proposed rheumatoid arthritis (RA) drug “Plivensia (sirukumab).” The Arthritis Advisory […]

James Humann

MASS TORT UPDATE: District Court in Cook IVC Filter Litigation Denies Defendant’s Appeal to Block the Deposition of its Former President

The District judge held that a review of the sealed documents shows Cook’s former president was involved with the “strategic decisions regarding the enhancement of the Tulip filter and the development of the Celect filter to increase market share. … Most importantly, the documents reflect that he was aware of the risk that both IVC filters could perforate the wall of the vena cava.”